2015
DOI: 10.1111/evj.12477
|View full text |Cite
|
Sign up to set email alerts
|

Equine allogeneic umbilical cord blood derived mesenchymal stromal cells reduce synovial fluid nucleated cell count and induce mild self‐limiting inflammation when evaluated in an lipopolysaccharide induced synovitis model

Abstract: Allogeneic CB-MSCs reduced synovial fluid cell populations and stimulated mild self-limiting inflammation in the synovitis model. Continued evaluation of the effects of i.a. CB-MSC therapy on synovitis in horses is needed to evaluate anti- and proinflammatory properties of CB-MSCs. Immediate interests are dose, timing of treatment, and treatment frequency.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

7
43
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(52 citation statements)
references
References 34 publications
7
43
0
Order By: Relevance
“…[119][120][121][122][123] Although it is a model of acute synovitis, it does induce significant increases in synovial fluid MMP activity and markers of type II collagen and proteoglycan degradation (C2C and 3-B-3) and synthesis (CPII and CS-846) that last for at least 1 week. 103,119,124 Moreover, if sustained by weekly stimulation for up to 12 weeks, the synovitis model induces hallmark features of OA in the synovium and cartilage in addition to clinical and radiographic changes, comparable to naturally occurring OA. [125][126][127] Given the strong agreement between our in vitro model and our in vivo study treating acute synovitis with BMNC, 37 this in vitro model should be considered for future studies assessing the mechanism of articular cell biology, pathobiology, and drug testing.…”
Section: Discussionmentioning
confidence: 99%
“…[119][120][121][122][123] Although it is a model of acute synovitis, it does induce significant increases in synovial fluid MMP activity and markers of type II collagen and proteoglycan degradation (C2C and 3-B-3) and synthesis (CPII and CS-846) that last for at least 1 week. 103,119,124 Moreover, if sustained by weekly stimulation for up to 12 weeks, the synovitis model induces hallmark features of OA in the synovium and cartilage in addition to clinical and radiographic changes, comparable to naturally occurring OA. [125][126][127] Given the strong agreement between our in vitro model and our in vivo study treating acute synovitis with BMNC, 37 this in vitro model should be considered for future studies assessing the mechanism of articular cell biology, pathobiology, and drug testing.…”
Section: Discussionmentioning
confidence: 99%
“…The TTJ, like the MCJ, has distinct advantages for joint studies, including its accessibility, and a large volume of synovial fluid for sampling. A previous study compared the TTJ to the MCJ to analyze joint responses to a therapeutic intervention (stem cells) following injection of an inflammatory agent ( 14 ). This study made the assumption that the TTJ and the MCJ would react similarly to lipopolysaccharide.…”
Section: Discussionmentioning
confidence: 99%
“…A recent study ( 7 ) and the experiences of the authors of this current study with rIL-1β in the tibiotarsal joint (TTJ) led to the question whether the TTJ may have a different clinical and cytological response to the administration of rIL-1β than described for the MCJ. We felt this was an important question because previous studies have assumed the response to an inflammatory agent is equivalent between MCJ and TTJ and have drawn conclusions regarding the immunomodulatory ability of treatments such as mesenchymal stem cells using TTJ and MCJ as equivalent joints to investigate treatments ( 14 ). Further, variability in the TTJ and MCJ joint is important when determining the dose of rIL-1β appropriate for research studies, while comparing treatment responses and evaluating treatment strategies and clinical responses.…”
Section: Introductionmentioning
confidence: 99%
“…It can be successfully treated with biologically based therapies such as platelet-rich plasma, or autologous conditioned serum (44, 45), or NSAIDs such as Ibuprofen or Naproxen (46). The MSCs-based therapies diminish the inflammatory response itself (12) and the intra-articular administration of MSCs has been found to reduce the nucleated cell counts in SF (47). Many authors have hypothesized that cell-free therapies may be safer and affordable than cell-based therapies (17, 18).…”
Section: Discussionmentioning
confidence: 99%